Entrectinib

Introduction: What is Entrectinib?

Entrectinib is a targeted therapy medication primarily used in the treatment of certain types of cancer. It is classified as a tyrosine kinase inhibitor, which means it works by blocking specific proteins that promote cancer cell growth. Entrectinib is particularly effective against tumors that have specific genetic mutations, making it a personalized treatment option for patients with these mutations.

Uses of Entrectinib

Entrectinib is approved for the treatment of several types of cancer, including:

• Non-Small Cell Lung Cancer (NSCLC): Specifically for patients with ROS1-positive NSCLC.
• Solid tumors: Indicated for adult and pediatric patients with solid tumors that are NTRK gene fusion-positive.

How It Works

Entrectinib works by inhibiting specific tyrosine kinases, including ROS1, TRKA, TRKB, and TRKC, which are involved in cancer cell growth and survival. These proteins are involved in signaling pathways that promote cell division and growth. By blocking these signals, Entrectinib helps to stop the growth of cancer cells, leading to tumor shrinkage or stabilization. In simpler terms, it acts like a "brake" on the cancer cells, preventing them from multiplying uncontrollably.

Dosage and Administration

Entrectinib is typically administered in tablet form. The standard dosage for adults is 600 mg taken orally once daily. For pediatric patients, the dosage may vary based on body weight and should be determined by a healthcare provider. It is important to take Entrectinib at the same time each day, with or without food, to maintain consistent levels of the medication in the body.

Side Effects of Entrectinib

Like all medications, Entrectinib can cause side effects. Common side effects include:

• Fatigue
• Nausea
• Diarrhea
• Constipation
• Changes in taste
• Weight gain

Serious side effects may include:

• Liver problems (elevated liver enzymes)
• Heart issues (including QT prolongation and congestive heart failure)
• Central nervous system effects (dizziness, confusion)
• Severe allergic reactions

Patients should report any unusual symptoms to their healthcare provider promptly.

Drug Interactions

Entrectinib can interact with several medications, which may affect how it works or increase the risk of side effects. Major drug interactions include:

• Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir)
• Strong CYP3A4 inducers (e.g., rifampin, St. John's Wort)
• Other cancer therapies that may affect liver enzymes

It is crucial to inform your healthcare provider about all medications, supplements, and herbal products you are taking.

Benefits of Entrectinib

The clinical advantages of using Entrectinib include:

• Targeted Therapy: It specifically targets cancer cells with genetic mutations, potentially leading to better outcomes.
• Oral Administration: The convenience of taking a pill rather than undergoing injections or infusions.
• Personalized Treatment: It allows for tailored treatment plans based on genetic testing results, improving the chances of effectiveness.

Contraindications of Entrectinib

Certain individuals should avoid using Entrectinib, including:

• Pregnant or breastfeeding women, unless the potential benefit justifies the potential risk to the fetus or infant.
• Patients with severe hepatic impairment should use Entrectinib with caution and under close medical supervision.
• Individuals with known hypersensitivity to Entrectinib or any of its components.

Precautions and Warnings

Before starting Entrectinib, patients should undergo specific lab tests to monitor liver function and heart health. It is essential to discuss any preexisting health conditions with a healthcare provider. Patients should also be aware of the potential for drug interactions and should not start or stop any medications without consulting their doctor.

FAQs

What is Entrectinib used for?

Entrectinib is used to treat certain types of cancer, including non-small cell lung cancer and solid tumors with specific genetic mutations.

How is Entrectinib taken?

It is taken orally in tablet form, usually 600 mg once daily.

What are the common side effects?

Common side effects include fatigue, nausea, diarrhea, and changes in taste.

Can I take Entrectinib with other medications?

You should inform your doctor about all medications you are taking, as some may interact with Entrectinib.

Is Entrectinib safe during pregnancy?

No, it is not recommended for use during pregnancy due to potential harm to the fetus.

How does Entrectinib work?

It blocks specific proteins that promote cancer cell growth, helping to stop tumor growth.

What should I do if I miss a dose?

If you miss a dose, take it as soon as you remember. If it's close to the next dose, skip the missed dose and continue with your regular schedule.

Are there any serious side effects?

Yes, serious side effects can include liver problems and heart issues. Report any unusual symptoms to your doctor.

Can children take Entrectinib?

Yes, but the dosage for pediatric patients should be determined by a healthcare provider based on body weight.

How long will I need to take Entrectinib?

The duration of treatment varies based on individual response and should be discussed with your healthcare provider.

Brand Names

Entrectinib is marketed under the brand name Rozlytrek.

Conclusion

Entrectinib represents a significant advancement in targeted cancer therapy, offering hope to patients with specific genetic mutations. Its ability to inhibit cancer cell growth while being administered conveniently as a tablet makes it a valuable option in oncology. As with any medication, it is essential to discuss potential benefits and risks with a healthcare provider to ensure the best treatment plan.